We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current OBIO market cap is 187.03M. The company's latest EPS is USD -1.2922 and P/E is -3.79.
| Quarter End | Mar 2023 | Jun 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
| Total Revenue | 1.16M | 915k | 620k | 778k | 987k |
| Operating Income | -11.55M | -12.96M | -14.42M | -16.86M | -16.34M |
| Net Income | -10.94M | -12.05M | -13.46M | -15.98M | -15.43M |
| Year End 31 December 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 2.76M |
| Operating Income | -180k | -395k | -3.08M | -51.51M |
| Net Income | -174k | -379k | -2.74M | -49.12M |
| Quarter End | Mar 2023 | Jun 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
| Total Assets | 136.28M | 125.88M | 82.63M | 72.38M | 75.32M |
| Total Liabilities | 36.53M | 36.44M | 25.44M | 28.26M | 29.1M |
| Total Equity | 99.75M | 89.44M | 57.19M | 44.13M | 46.22M |
| Year End 31 December 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 162.16M | 161.82M | 68.08M | 95.21M |
| Total Liabilities | 5.72M | 5.77M | 7.34M | 27.17M |
| Total Equity | 5M | -3.94M | -6.95M | 68.04M |
| Quarter End | Mar 2023 | Jun 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
| Operating | -14.38M | -24.87M | -13.11M | -23.32M | -37.02M |
| Investing | -43.53M | -35.41M | 5.86M | 16.29M | 16.84M |
| Financing | 56.82M | 56.91M | 18k | 189k | 15.22M |
| Year End 31 December 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -259k | -273k | -1.58M | -46.13M |
| Investing | -160M | N/A | 92.59M | 10.69M |
| Financing | 162.29M | N/A | -92.59M | 46.22M |
| Market Cap | 187.03M |
| Price to Earnings Ratio | -3.79 |
| Price to Sales Ratio | 67.49 |
| Price to Cash Ratio | 6.1 |
| Price to Book Ratio | 2.74 |
| Dividend Yield | - |
| Shares Outstanding | 38.01M |
| Average Volume (1 week) | 60.5k |
| Average Volume (1 Month) | 56.73k |
| 52 Week Change | -51.04% |
| 52 Week High | 10.44 |
| 52 Week Low | 4.22 |
| Spread (Intraday) | 0.69 (13.8%) |
| Company Name | Orchestra BioMed Holdings Inc |
| Address |
po box 309 grand cayman KY1 1104 |
| Website | https:// |
| Industry | blank checks (6770) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
